EUVIMEDEUVIMED entdecken
Crossref

Disability outcome and associated factors in patients with myotonic dystrophy type 1: A retrospective cohort analysis

Wenhan Zhang, Huahua Zhong, Yuean Yang, Fangyuan Qian, Zhijie Lu, Li Zeng, Jing Miao, Xuefan Yu, Qing Ke, Xueli Chang, Changxia Liu, Lingchun Liu und 14 weitere

Intractable & Rare Diseases Research · 2026

DOI: 10.5582/irdr.2026.01044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intractable & Rare Diseases Research, 2026. Verfasst von Wenhan Zhang und 25 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhang, W., Zhong, H., Yang, Y., Qian, F., Lu, Z., Zeng, L., Miao, J., Yu, X., Ke, Q., Chang, X., Liu, C., Liu, L., Chen, L., Guo, J., Li, D., Zhang, Y., Yan, X., Jiang, Q., Zhao, Z., …, & Luo, S. (2026). Disability outcome and associated factors in patients with myotonic dystrophy type 1: A retrospective cohort analysis. Intractable & Rare Diseases Research. https://doi.org/10.5582/irdr.2026.01044

Vancouver

Zhang W, Zhong H, Yang Y, Qian F, Lu Z, Zeng L, et al. Disability outcome and associated factors in patients with myotonic dystrophy type 1: A retrospective cohort analysis. Intractable & Rare Diseases Research. 2026. doi:10.5582/irdr.2026.01044

BibTeX
@article{Zhang2026,
  author = {Zhang, Wenhan and Zhong, Huahua and Yang, Yuean and Qian, Fangyuan and Lu, Zhijie and Zeng, Li and Miao, Jing and Yu, Xuefan and Ke, Qing and Chang, Xueli and Liu, Changxia and Liu, Lingchun and Chen, Lixia and Guo, Jia and Li, Dan and Zhang, Yali and Yan, Xianni and Jiang, Qilong and Zhao, Zhe and Xi, Jianying and Zhu, Wenhua and Lu, Jiahong and Liu, Fuchen and Liu, Ying and Zhao, Chongbo and Luo, Sushan},
  title = {Disability outcome and associated factors in patients with myotonic dystrophy type 1: A retrospective cohort analysis},
  journal = {Intractable & Rare Diseases Research},
  year = {2026},
  doi = {10.5582/irdr.2026.01044}
}
Kostenlos starten →